Clonal hematopoiesis of indeterminate potential was not associated with an increased risk for heart disease but was linked to ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 1 clinical study ...

Adam Elinoff will become Aglient Technologies' CFO on Nov. 17. (courtesy photo) Agilent Technologies, a supplier of laboratory medical equipment to the biotechnology industry that is based in Santa ...

Agilent Technologies Inc. (NYSE: A) today announced the appointment of Adam S. Elinoff as chief financial officer, effective ...

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the ...

The drug colchicine may reduce cardiovascular outcomes among patients with gout, based on a range of retrospective data that ...

Patients who depended on oral corticosteroids to care for their severe asthma experienced improvements in asthma control ...

ITM-11 significantly improved PFS and OS in GEP-NET patients compared to everolimus, with a favorable safety profile and higher overall response rates. Dosimetry data showed targeted tumor uptake with ...

The global regenerative medicine market is poised for remarkable expansion, expected to record a compound annual growth rate (CAGR) of around 17% during the forecast period. This surge is primarily ...

SAN FRANCISCO – OCTOBER 26, 2025 – New study findings show that utilizing super-high-pressure non-compliant balloons (NCB) is non-inferior to intravascular lithotripsy (IVL) balloon catheters for ...

Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, today announced the appointment of (“CPO”) ...